ResearcherThe University of MelbourneNo recent work listed

Yang Yang Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8787-1217; OpenAlex author ID A5100397691. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 2 papers

Papers 2

Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. Co-author DOI 10.1016/j.canlet.2019.12.020 ↗
Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway. Co-author DOI 10.3390/ijms21218035 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kai Wang · 2 shared papers, 2020 · strength 0.23
- Paper Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway. DOI 10.3390/ijms21218035 ↗
- Paper Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. DOI 10.1016/j.canlet.2019.12.020 ↗
Hong Zhen He · 2 shared papers, 2020 · strength 0.23
- Paper Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway. DOI 10.3390/ijms21218035 ↗
- Paper Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. DOI 10.1016/j.canlet.2019.12.020 ↗
Mehrdad Nikfarjam · 2 shared papers, 2020 · strength 0.23
- Paper Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway. DOI 10.3390/ijms21218035 ↗
- Paper Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. DOI 10.1016/j.canlet.2019.12.020 ↗
David Herrmann · 1 shared paper, 2020 · strength 0.10
- Paper Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. DOI 10.1016/j.canlet.2019.12.020 ↗
Paul Timpson · 1 shared paper, 2020 · strength 0.10
- Paper Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. DOI 10.1016/j.canlet.2019.12.020 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.